Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232

Cancer statistics, 2019

Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160

GSVA: gene set variation analysis for microarray and RNA-Seq data

Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440

The Molecular Signatures Database Hallmark Gene Set Collection

Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807

FactoMineR : An R Package for Multivariate Analysis

Lê, S., Josse, J., & Husson, F. (2008) · Journal of Statistical Software · doi:10.18637/jss.v025.i01 · Cited by 12,422

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486

Inferring tumour purity and stromal and immune cell admixture from expression data

Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,055

Adjusting batch effects in microarray expression data using empirical Bayes methods

Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950

Cancer Genome Landscapes

Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645

The Reactome pathway Knowledgebase

Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,965

VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint

Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954

The biology and management of non-small cell lung cancer

Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891

COSMIC: the Catalogue Of Somatic Mutations In Cancer

Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477

xCell: digitally portraying the tissue cellular heterogeneity landscape

Aran, D., Hu, Z., & Butte, A. J. (2017) · Genome Biology · doi:10.1186/s13059-017-1349-1 · Cited by 4,397

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

Colaprico, A., Silva, T. C., Olsen, C., Garofano, L., Cava, C., Garolini, D., Sabedot, T. S., Malta, T. M., Pagnotta, S. M., Castiglioni, I., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1507 · Cited by 4,205

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,922

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515

Defining a Cancer Dependency Map

Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201

Discovery and saturation analysis of cancer genes across 21 tumour types

Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096

CTLA-4 Control over Foxp3 + Regulatory T Cell Function

Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956

mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models

Scrucca, L., Fop, M., Murphy, T. B., & Adrian, E. R. (2016) · The R Journal · doi:10.32614/rj-2016-021 · Cited by 2,914

The Reactome Pathway Knowledgebase

Fabregat, A., Jupe, S., Matthews, L. R., Sidiropoulos, K., Gillespie, M. E., Garapati, P. V., Haw, R., Jassal, B., Korninger, F., May, B., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1132 · Cited by 2,862

TGF-β-induced epithelial to mesenchymal transition

Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804

Somatic mutations affect key pathways in lung adenocarcinoma

Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

Vasaikar, S. V., Straub, P., Wang, J., & Zhang, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1090 · Cited by 2,307

Comprehensive Characterization of Cancer Driver Genes and Mutations

Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,256

Metagenes and molecular pattern discovery using matrix factorization

Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

Du, P., Zhang, X., Huang, C.-C., Jafari, N., Kibbe, W. A., Hou, L., & Lin, S. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-587 · Cited by 2,136

Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data

Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

Ye, K., Schulz, M. H., Long, Q., Apweiler, R., & Ning, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp394 · Cited by 2,029

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964

The Reactome pathway knowledgebase

Croft, D., Mundo, A. F., Haw, R., Milacic, M., Weiser, J., Wu, G., Caudy, M., Garapati, P., Gillespie, M., Kamdar, M. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1102 · Cited by 1,889

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789

Proteogenomics connects somatic mutations to signalling in breast cancer

CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676

Strelka2: fast and accurate calling of germline and somatic variants

Kim, S., Scheffler, K., Halpern, A. L., Bekritsky, M. A., Noh, E., Källberg, M., Chen, X., Kim, Y., Beyter, D., Krusche, P., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0051-x · Cited by 1,643

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B. W., Latham, V. M., & Sullivan, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1122 · Cited by 1,636

Lung cancer in never smokers — a different disease

Sun, S., Schiller, J. H., & Gazdar, A. F. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2190 · Cited by 1,601

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0060-1 · Cited by 1,597

Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs

Saunders, C. T., Wong, W. S. W., Swamy, S., Becq, J., Murray, L. J., & Cheetham, R. K. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts271 · Cited by 1,589

A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics

Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A., Amini, B., Andersen, E., Andersson, A., Angelidou, P., Asplund, A., Asplund, C., et al. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500279-mcp200 · Cited by 1,560

A flexible R package for nonnegative matrix factorization

Gaujoux, R., & Seoighe, C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-367 · Cited by 1,516

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Key, N. S., Khorana, A. A., Kuderer, N. M., Bohlke, K., Lee, A. Y. Y., Arcelus, J. I., Wong, S. L., Balaban, E. P., Flowers, C. R., Francis, C. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01461 · Cited by 1,511

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

Jurtz, V. I., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,476

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.006 · Cited by 1,429

RET, ROS1 and ALK fusions in lung cancer

Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2658 · Cited by 1,320

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200

WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit

Wang, J., Vasaikar, S. V., Shi, Z., Greer, M., & Zhang, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx356 · Cited by 1,161

Characterizing the cancer genome in lung adenocarcinoma

Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105

MS-GF+ makes progress towards a universal database search tool for proteomics

Kim, S., & Pevzner, P. A. (2014) · Nature Communications · doi:10.1038/ncomms6277 · Cited by 1,098

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029

VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research

Lai, Z., Markovets, A. A., Ahdesmaki, M. J., Chapman, B., Hofmann, O., McEwen, R. K., Johnson, J., Dougherty, B. A., Barrett, J. C., & Dry, J. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw227 · Cited by 971

Lung cancer in never smokers – A review

Couraud, S., Zalcman, G., Milleron, B. J., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 962

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 939

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Chen, Y.-N. P., LaMarche, M. J., Chan, H. M., Fekkes, P., Garcia-Fortanet, J., Acker, M. G., Antonakos, B., Chen, C. H.-T., Chen, Z., Cooke, V. G., et al. (2016) · Nature · doi:10.1038/nature18621 · Cited by 925

Functional normalization of 450k methylation array data improves replication in large cancer studies

Fortin, J.-P., Labbe, A., Lemire, M., Zanke, B. W., Hudson, T. J., Fertig, E. J., Greenwood, C. M. T., & Hansen, K. D. (2014) · Genome biology · doi:10.1186/s13059-014-0503-2 · Cited by 893

Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity

Fang, D., Hawke, D. H., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T. R., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 888

Reactome pathway analysis: a high-performance in-memory approach

Fabregat, A., Sidiropoulos, K., Viteri, G., Forner, O., Marín-García, P., Arnau, V., D’Eustachio, P., Stein, L. D., & Hermjakob, H. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1559-2 · Cited by 884

Colonic epithelial cell diversity in health and inflammatory bowel disease

Parikh, K., Antanaviciute, A., Fawkner-Corbett, D., Jagielowicz, M., Aulicino, A., Lagerholm, B. C., Davis, S. A., Kinchen, J. W., Chen, H. H., Alham, N. K., et al. (2019) · Nature · doi:10.1038/s41586-019-0992-y · Cited by 878

DGIdb 3.0: a redesign and expansion of the drug–gene interaction database

Cotto, K. C., Wagner, A. H., Feng, Y.-Y., Kiwala, S., Coffman, A. C., Spies, G., Wollam, A., Spies, N. C., Griffith, O. L., & Griffith, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1143 · Cited by 877

Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis

Kim, H., & Park, H. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm134 · Cited by 865

Integrative clinical genomics of metastatic cancer

Robinson, D. R., Wu, Y.-M., Lonigro, R. J., Vats, P., Cobain, E., Everett, J., Cao, X., Rabban, E., Kumar-Sinha, C., Raymond, V., et al. (2017) · Nature · doi:10.1038/nature23306 · Cited by 863

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

Vigil, D., Cherfils, J., Rossman, K. L., & Der, C. J. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2960 · Cited by 850

Respiratory epithelial cells orchestrate pulmonary innate immunity

Whitsett, J. A., & Alenghat, T. (2014) · Nature Immunology · doi:10.1038/ni.3045 · Cited by 846

KIF5B-RET fusions in lung adenocarcinoma

Kohno, T., Ichikawa, H., Totoki, Y., Yasuda, K., Hiramoto, M., Nammo, T., Sakamoto, H., Tsuta, K., Furuta, K., Shimada, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2644 · Cited by 834

OptiType: precision HLA typing from next-generation sequencing data

Szolek, A., Schubert, B., Mohr, C., Sturm, M., Feldhahn, M., & Kohlbacher, O. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu548 · Cited by 774

Muc5b is required for airway defence

Roy, M. G., Livraghi-Butrico, A., Fletcher, A. A., McElwee, M. M., Evans, S. E., Boerner, R. M., Alexander, S. N., Bellinghausen, L. K., Song, A. S., Petrova, Y. M., et al. (2014) · Nature · doi:10.1038/nature12807 · Cited by 764

Lung Cancer in Never Smokers: A Review

Subramanian, J., & Govindan, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8015 · Cited by 705

A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries

Fisher, S., Barry, A. J., Abreu, J., Minie, B., Nolan, J., Delorey, T. M., Young, G., Fennell, T. J., Allen, A., Ambrogio, L., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-1-r1 · Cited by 676

Protein-tyrosine phosphatases and cancer

Östman, A., Hellberg, C. B., & Böhmer, F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1837 · Cited by 665

A Compendium of Mutational Signatures of Environmental Agents

Kucab, J. E., Zou, X., Morganella, S., Joel, M., Nanda, A. S., Nagy, E., Gomez, C., Degasperi, A., Harris, R., Jackson, S. P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.001 · Cited by 660

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Li, S., Shen, D., Shao, J., Crowder, R. J., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 637

Structural basis of Keap1 interactions with Nrf2

Canning, P., Sorrell, F. J., & Bullock, A. N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.034 · Cited by 620

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

Gao, Q., Liang, W.-W., Foltz, S. M., Mutharasu, G., Jayasinghe, R. G., Cao, S., Liao, W., Reynolds, S. M., Wyczalkowski, M. A., Yao, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.050 · Cited by 608

BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis

Wiel, C., Le Gal, K., Ibrahim, M. X., Jahangir, C. A., Kashif, M., Yao, H., Ziegler, D. V., Xu, X., Ghosh, T., Mondal, T., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.005 · Cited by 579

Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1

Lignitto, L., LeBoeuf, S. E., Homer, H., Jiang, S., Askenazi, M., Karakousi, T. R., Pass, H. I., Bhutkar, A. J., Tsirigos, A., Ueberheide, B., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.003 · Cited by 573

The KEAP1–NRF2 System in Cancer

Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

Weinert, B. T., Narita, T., Satpathy, S., Srinivasan, B., Hansen, B. K., Scholz, C. W., Hamilton, W. B., Zucconi, B. E., Wang, W., Liu, W. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.033 · Cited by 523

A Genomics-Based Classification of Human Lung Tumors

Thomas, R. K., Buettner, R., & Wolf, J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006802 · Cited by 516

Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer

Wang, Y., Kuan, P. J., Xing, C., Cronkhite, J. T., Torres, F., Rosenblatt, R. L., DiMaio, J. M., Kinch, L. N., Grishin, N. V., & Garcia, C. K. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.010 · Cited by 513

Proteogenomic Characterization of Endometrial Carcinoma

Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485

SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database

Jewison, T., Su, Y., Disfani, F. M., Liang, Y., Knox, C., Maciejewski, A., Poelzer, J., Huynh, J., Zhou, Y. L., Arndt, D., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1067 · Cited by 476

Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry

Mertins, P., Tang, L. C., Krug, K., Clark, D. J., Gritsenko, M., Chen, L., Clauser, K. R., Clauss, T. R., Shah, P., Gillette, M. A., et al. (2018) · Nature Protocols · doi:10.1038/s41596-018-0006-9 · Cited by 466

Dynamic profiling of the protein life cycle in response to pathogens

Jovanovic, M., Rooney, M. S., Mertins, P., Przybylski, D., Chevrier, N., Satija, R., Rodriguez, E. H., Fields, A. P., Schwartz, S., Raychowdhury, R., et al. (2015) · Science · doi:10.1126/science.1259038 · Cited by 460

Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway

Aronheim, A., Engelberg, D., Li, N., Al-Alawi, N., Schlessinger, J., & Karin, M. (1994) · Cell · doi:10.1016/0092-8674(94)90271-2 · Cited by 458

Targeting the IDO1 pathway in cancer: from bench to bedside

Liu, M., Wang, X., Wang, L., Ma, X., Gong, Z., Zhang, S., & Li, Y. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0644-y · Cited by 456

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

de Almeida, L. G. P., Sakabe, N. J., deOliveira, A. R., da Silva, M. C. C., Mundstein, A. S., Cohen, T., Chen, Y., Chua, R., Gurung, S., Gnjatic, S., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn673 · Cited by 436

Regulation of the p300 HAT domain via a novel activation loop

Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb740 · Cited by 423

Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors

Kim, J., Mouw, K. W., Polak, P. P., Braunstein, L. Z., Kamburov, A., Tiao, G., Kwiatkowski, D. J., Rosenberg, J. E., Allen, E. M. V., D’Andrea, A. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3557 · Cited by 411

Smoking and Lung Cancer: The Role of Inflammation

Walser, T. C., Cui, X., Yanagawa, J., Lee, J. M., Heinrich, E., Lee, G., Sharma, S., & Dubinett, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200809-100th · Cited by 402

Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.

Bennett, A. M., Tang, T. L., Sugimoto, S., Walsh, C. T., & Neel, B. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7335 · Cited by 397

Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction

Hillig, R. C., Sautier, B., Schroeder, J., Moosmayer, D., Hilpmann, A., Stegmann, C. M., Werbeck, N. D., Briem, H., Boemer, U., Weiske, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812963116 · Cited by 388

Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

Chen, Y.-J., Roumeliotis, T. I., Chang, Y.-H., Chen, C.-T., Han, C.-L., Lin, M.-H., Chen, H.-W., Chang, G.-C., Chang, Y.-L., Wu, C.-T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.012 · Cited by 382

SMPDB: The Small Molecule Pathway Database

Frolkis, A., Knox, C., Lim, E. L., Jewison, T., Law, V., Hau, D., Liu, P., Gautam, B., Ly, S., Guo, A. C., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1002 · Cited by 376

Targeting RET in Patients With RET -Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Gautschi, O. P., Milia, J., Filleron, T., Wolf, J., Carbone, D. P., Owen, D. H., Camidge, D. R., Narayanan, V., Doebele, R. C., Besse, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.9352 · Cited by 364

A Curated Resource for Phosphosite-specific Signature Analysis

Krug, K., Mertins, P., Zhang, B., Hornbeck, P. V., Raju, R., Ahmad, R., Szucs, M. J., Mundt, F., Forestier, D., Jané‐Valbuena, J., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.000943 · Cited by 339

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Kim, J., Hu, Z., Cai, L., Li, K., Choi, E., Faubert, B., Bezwada, D., Rodriguez-Canales, J., Villalobos, P., Lin, Y.-F., et al. (2017) · Nature · doi:10.1038/nature22359 · Cited by 325

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

Chen, G., Gharib, T. G., Huang, C.-C., Thomas, D. G., Shedden, K., Taylor, J. M. G., Kardia, S. L. R., Misek, D. E., Giordano, T. J., Iannettoni, M. D., et al. (2002) · PubMed · Cited by 317

SnapShot: Immune Checkpoint Inhibitors

Abril-Rodríguez, G., & Ribas, A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.010 · Cited by 311

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition

Cloonan, N., Brown, M. K., Steptoe, A. L., Wani, S., Chan, W. L., Forrest, A. R., Kolle, G., Gabrielli, B., & Grimmond, S. M. (2008) · Genome Biology · doi:10.1186/gb-2008-9-8-r127 · Cited by 304

Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells

Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 297

Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

Wilkerson, M. D., Yin, X., Walter, V., Zhao, N., Cabanski, C. R., Hayward, M. C., Miller, C. R., Socinski, M. A., Parsons, A. M., Thorne, L. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036530 · Cited by 295

The incidence of venous thromboembolism among patients with primary lung cancer

Chew, H. K., Davies, A. M., Wun, T., HARVEY, D., Zhou, H., & WHITE, R. H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02908.x · Cited by 292

i-Tracker: For quantitative proteomics using iTRAQ™

Shadforth, I., Dunkley, T. P. J., Lilley, K. S., & Bessant, C. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-145 · Cited by 281

Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung Disease

Pastva, A. M., Wright, J. R., & Williams, K. L. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-018aw · Cited by 277

Automatic Relevance Determination in Nonnegative Matrix Factorization with the /spl beta/-Divergence

Tan, V. Y. F., & Févotte, C. (2012) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2012.240 · Cited by 271

Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell Signaling

Lu, W., Gong, D., Bar-Sagi, D., & Cole, P. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00369-0 · Cited by 268

p120-Catenin Mediates Inflammatory Responses in the Skin

Pérez‐Moreno, M., Davis, M. A., Wong, E., Pasolli, H. A., Reynolds, A. B., & Fuchs, E. V. (2006) · Cell · doi:10.1016/j.cell.2005.11.043 · Cited by 267

Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1

Fukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 267

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

Aceto, N., Sausgruber, N., Brinkhaus, H., Gaidatzis, D., Martiny‐Baron, G., Mazzarol, G., Confalonieri, S., Quarto, M., Hu, G., Balwierz, P. J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2645 · Cited by 265

Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers

Chapman, A. M., Sun, K., Ruestow, P., Cowan, D. M., & Madl, A. K. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.10.010 · Cited by 263

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

Kasar, S. N., Kim, J., Improgo, R., Tiao, G., Polak, P. P., Haradhvala, N. J., Lawrence, M. S., Kieżun, A., Fernandes, S. M., Bahl, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9866 · Cited by 257

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer

Shimizu, K., Nakata, M., Hirami, Y., Yukawa, T., Maeda, A., & Tanemoto, K. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d60fd7 · Cited by 244 · cited 2×

Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation

Matozaki, T., Murata, Y., Saito, Y., Okazawa, H., & Ohnishi, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01257.x · Cited by 240

Detecting multiple change-points in the mean of Gaussian process by model selection

Lebarbier, É. (2004) · Signal Processing · doi:10.1016/j.sigpro.2004.11.012 · Cited by 225

A cross-package Bioconductor workflow for analysing methylation array data

Maksimovic, J., Phipson, B., & Oshlack, A. (2016) · F1000Research · doi:10.12688/f1000research.8839.3 · Cited by 224

Coupling and coordination in gene expression processes: a systems biology view

Komili, S., & Silver, P. A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2223 · Cited by 218

Grb2 signaling in cell motility and cancer

Giubellino, A., Burke, T. R., & Bottaro, D. P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.8.1021 · Cited by 215

A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation

Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J., & Raynal, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410012200 · Cited by 210

Topoisomerase IIα in chromosome instability and personalized cancer therapy

Chen, T., Sun, Y. K., Ji, P., Kopetz, S., & Zhang, W. (2014) · Oncogene · doi:10.1038/onc.2014.332 · Cited by 207

An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity

Nayak, A., Dodagatta-Marri, E., Tsolaki, A. G., & Kishore, U. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00131 · Cited by 206

Claudin-18–mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis

Zhou, B., Flodby, P., Luo, J., Castillo, D. R., Liu, Y., Yu, F., McConnell, A. M., Varghese, B. A., Li, G., Chimge, N., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci90429 · Cited by 180

Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow

Svinkina, T., Gu, H., Silva, J. C., Mertins, P., Qiao, J., Fereshetian, S., Jaffe, J. D., Kuhn, E. W., Udeshi, N. D., & Carr, S. A. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o114.047555 · Cited by 179

Protein Identification Using Customized Protein Sequence Databases Derived from RNA-Seq Data

Wang, X., Slebos, R. J. C., Wang, D., Halvey, P. J., Tabb, D. L., Liebler, D. C., & Zhang, B. (2012) · Journal of Proteome Research · doi:10.1021/pr200766z · Cited by 173

Large-scale profiling of microRNAs for The Cancer Genome Atlas

Chu, A., Robertson, G., Brooks, D., Mungall, A. J. J., Birol, İ., Coope, R., Ma, Y. P., Jones, S. J. M., & Marra, M. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv808 · Cited by 171

PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs

Prahallad, A., Heynen, G. J. J. E., Germano, G., Willems, S. M., Evers, B., Vecchione, L., Gambino, V., Lieftink, C., Beijersbergen, R. L., Di Nicolantonio, F., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.037 · Cited by 168

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation

Romano, G., Acunzo, M., Garofalo, M., Leva, G. D., Cascione, L., Zanca, C., Bolon, B. N., Condorelli, G., & Croce, C. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207917109 · Cited by 164

Regulation of the Mitogen-activated Protein Kinase Signaling Pathway by SHP2

Cunnick, J. M., Meng, S., Ren, Y., Desponts, C., Wang, H., Djeu, J. Y., & Wu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110547200 · Cited by 162

customProDB: an R package to generate customized protein databases from RNA-Seq data for proteomics search

Wang, X., & Zhang, B. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt543 · Cited by 162

DNA methylation–based immune response signature improves patient diagnosis in multiple cancers

Jeschke, J., Bizet, M., Desmedt, C., Calonne, E., Dedeurwaerder, S., Garaud, S., Koch, A., Larsimont, D., Salgado, R., den Eynden, G. V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91095 · Cited by 157

Pharmacological targeting of RAS: recent success with direct inhibitors

O’Bryan, J. P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.021 · Cited by 153

Absolute Proteome and Phosphoproteome Dynamics during the Cell Cycle of Schizosaccharomyces pombe (Fission Yeast)

Carpy, A., Krug, K., Graf, S., Koch, A., Popic, S., Hauf, S., & Maček, B. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035824 · Cited by 151

Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities

Ganapathy‐Kanniappan, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.04.002 · Cited by 144

Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis

Wen, B., Li, K., Zhang, Y., & Zhang, B. (2020) · Nature Communications · doi:10.1038/s41467-020-15456-w · Cited by 144

CD73–Adenosine: A Next-Generation Target in Immuno-Oncology

Allard, D., Allard, B., Gaudreau, P.-O., Chrobák, P., & Stagg, J. (2016) · Immunotherapy · doi:10.2217/imt.15.106 · Cited by 142

Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9

Scanlan, M. J., Altorki, N. K., Gure, A. O., Williamson, B., Jungbluth, A. A., Chen., Y., & Old, L. J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00385-7 · Cited by 140

The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma

Tufo, G., Jones, A. W. E., Wang, Z., Hamelin, J., Tajeddine, N., Esposti, D. D., Martel, C., Boursier, C., Gallerne, C., Migdal, C., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.193 · Cited by 139

PDV: an integrative proteomics data viewer

Li, K., Vaudel, M., Zhang, B., Ren, Y., & Wen, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty770 · Cited by 126

Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium

Salomonis, N., Dexheimer, P. J., Omberg, L., Schroll, R., Bush, S., Huo, J. S., Schriml, L. M., Sui, S. H., Keddache, M. A., Mayhew, C. N., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.006 · Cited by 125

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

Ruggles, K. V., Tang, Z., Wang, X., Grover, H., Askenazi, M., Teubl, J., Cao, S., McLellan, M. D., Clauser, K. R., Tabb, D. L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056226 · Cited by 117

A cross-package Bioconductor workflow for analysing methylation array data

Maksimovic, J., Phipson, B., & Oshlack, A. (2016) · F1000Research · doi:10.12688/f1000research.8839.1 · Cited by 115

Recruitment of Phosphorylated NPM1 to Sites of DNA Damage through RNF8-Dependent Ubiquitin Conjugates

Koike, A., Nishikawa, H., Wu, W., Okada, Y., Venkitaraman, A. R., & Ohta, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0382 · Cited by 114

Microscaled proteogenomic methods for precision oncology

Satpathy, S., Jaehnig, E. J., Krug, K., Kim, B., Saltzman, A. B., Chan, D. W., Holloway, K. R., Anurag, M., Huang, C. L., Singh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14381-2 · Cited by 113

Rapid and deep-scale ubiquitylation profiling for biology and translational research

Udeshi, N. D., Mani, D. R., Satpathy, S., Fereshetian, S., Gasser, J. A., Svinkina, T., Olive, M. E., Ebert, B. L., Mertins, P., & Carr, S. A. (2020) · Nature Communications · doi:10.1038/s41467-019-14175-1 · Cited by 110

Oncogenic KRAS‐induced interleukin‐8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non‐small cell lung cancer

Sunaga, N., Imai, H., Shimizu, K., Shames, D. S., Kakegawa, S., Girard, L., Sato, M., Kaira, K., Ishizuka, T., Gazdar, A. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26164 · Cited by 103

PepQuery enables fast, accurate, and convenient proteomic validation of novel genomic alterationsPreprint

Wen, B., Wang, X., & Zhang, B. (2019) · Genome Research · doi:10.1101/gr.235028.118 · Cited by 102

Matrix Metalloproteinase 12 Overexpression in Lung Epithelial Cells Plays a Key Role in Emphysema to Lung Bronchioalveolar Adenocarcinoma Transition

Qu, P., Du, H., Wang, X., & Yan, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0577 · Cited by 99

The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis

Ducray, S. P., Natarajan, K., Garland, G. D., Turner, S. D., & Egger, G. (2019) · Cancers · doi:10.3390/cancers11081074 · Cited by 99

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk

Salerno, E. P., Bedognetti, D., Mauldin, I. S., Deacon, D. H., Shea, S. M., Pinczewski, J., Obeid, J. M., Coukos, G., Wang, E., Gajewski, T. F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1240857 · Cited by 98

ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES

Sokolov, A., Paull, E., & Stuart, J. M. (2015) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814749411_0037 · Cited by 94

Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis

Tang, D. L., Liu, J. J., Rundle, A., Neslund-Dudas, C. M., Savera, A. T., Bock, C. H., Nock, N. L., Yang, J. J., & Rybicki, B. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0973 · Cited by 92

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer

Lochhead, P. J., Imamura, Y., Morikawa, T., Kuchiba, A., Yamauchi, M., Liao, X., Qian, Z. R., Nishihara, R., Wu, K., Meyerhardt, J. A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.021 · Cited by 91

β-Catenin Contributes to Lung Tumor Development Induced by EGFR Mutations

Nakayama, S., Sng, N., Carretero, J., Welner, R. S., Hayashi, Y., Yamamoto, M., Tan, A. J., Yamaguchi, N., Yasuda, H., Li, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0184 · Cited by 91

Heme oxygenase inhibition in cancers: possible tools and targets

Podkalicka, P., Mucha, O., Józkowicz, A., Dulak, J., & Łoboda, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73879 · Cited by 90

Mammalian Son of Sevenless Guanine Nucleotide Exchange Factors: Old Concepts and New Perspectives

Rojas, J. M., Oliva, J. L., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911408078 · Cited by 89

Genetic Deletion of RALA and RALB Small GTPases Reveals Redundant Functions in Development and Tumorigenesis

Peschard, P., McCarthy, A., Leblanc-Dominguez, V., Yeo, M., Guichard, S., Stamp, G., & Marshall, C. J. (2012) · Current Biology · doi:10.1016/j.cub.2012.09.013 · Cited by 82

Oncofetal protein IMP3

Jiang, Z., Lohse, C. M., Chu, P. G., Wu, C., Woda, B. A., Rock, K. L., & Kwon, E. D. (2008) · Cancer · doi:10.1002/cncr.23484 · Cited by 82

The role of Ral A in epidermal growth factor receptor-regulated cell motility.

Gildea, J. J., Harding, M. A., Seraj, M. J., Gulding, K. M., & Theodorescu, D. (2002) · PubMed · Cited by 81

Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives

Daily, K., Ho Sui, S. J., Schriml, L. M., Dexheimer, P. J., Salomonis, N., Schroll, R., Bush, S., Keddache, M., Mayhew, C., Lotia, S., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.30 · Cited by 81

SnapShot: Ras Signaling

Cully, M., & Downward, J. (2008) · Cell · doi:10.1016/j.cell.2008.06.020 · Cited by 80

Carcinogenicity of the Chlorination Disinfection By-Product MX

McDonald, T., & Komulainen, H. (2005) · Journal of Environmental Science and Health Part C · doi:10.1080/10590500500234988 · Cited by 80

Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma

Jariwala, N. H., Rajasekaran, D., Mendoza, R. G., Shen, X., Siddiq, A., Akiel, M., Robertson, C. L., Subler, M. A., Windle, J. J., Fisher, P. B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0298 · Cited by 78

Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK*

Kamioka, Y., Yasuda, S., Fujita, Y., Aoki, K., & Matsuda, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135517 · Cited by 76

Five new human cancer‐germline genes identified among 12 genes expressed in spermatogonia

Loriot, A. E., Boon, T., & Smet, C. D. (2003) · International Journal of Cancer · doi:10.1002/ijc.11104 · Cited by 75

Genetic Variants of Surfactant Proteins A, B, C, and D in Bronchopulmonary Dysplasia

Pavlovic, J., Papagaroufalis, C., Xanthou, M., Liu, W., Fan, R., Thomas, N. J., Apostolidou, I., Papathoma, E., Megaloyianni, E., DiAngelo, S. L., et al. (2006) · Disease Markers · doi:10.1155/2006/817805 · Cited by 71

A Comparison of Nine Confidence Intervals for a Poisson Parameter When the Expected Number of Events is ≤ 5

Barker, L. E. (2002) · The American Statistician · doi:10.1198/000313002317572736 · Cited by 70

Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.

Vogel, W. F., & Ullrich, A. (1996) · PubMed · Cited by 69

High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer

Yang, C., Peng, P., Li, L., Shao, M., Zhao, J., Wang, L., Duan, F., Song, S., Wu, H., Zhang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep39044 · Cited by 67

Ral GTPases in tumorigenesis: Emerging from the shadows

Kashatus, D. F. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.020 · Cited by 66

Identification of Tcf-4 as a transcriptional target of p53 signalling

Rother, K., Johne, C., Spiesbach, K., Haugwitz, U., Tschöp, K., Wasner, M., Klein‐Hitpaß, L., Möröy, T., Mössner, J., & Engeland, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207464 · Cited by 65

Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival

Fahrmann, J. F., Grapov, D., Phinney, B. S., Stroble, C., DeFelice, B. C., Rom, W. N., Gandara, D. R., Zhang, Y., Fiehn, O., Pass, H. I., et al. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9132-y · Cited by 65

Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer

Zhang, W., Zhang, J., Zhang, Z., Guo, Y., Wu, Y., Wang, R., Wang, L., Mao, S., & Yao, X. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.012 · Cited by 65

Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway

Hosgood, H. D., Menashe, I., Shen, M., Yeager, M., Yuenger, J., Rajaraman, P., He, X., Chatterjee, N., Caporaso, N. E., Zhu, Y. L., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn178 · Cited by 64

MiR‐17‐5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21

Chen, C., Lu, Z., Yang, J., Hao, W.-C., Qin, Y., Wang, H., Xie, C., & Xie, R. (2016) · Cancer Medicine · doi:10.1002/cam4.863 · Cited by 63

Prognostic impact of Cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study

Fujise, N., Nanashima, A., Taniguchi, Y., Matsuo, S., Hatano, K., Matsumoto, Y., Tagawa, Y., & Ayabe, H. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00088-4 · Cited by 62

TAK -ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy

Santoro, R., Carbone, C., Piro, G., Chiao, P. J., & Melisi, D. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.004 · Cited by 61

GSTP1 methylation in cancer: a liquid biopsy biomarker?

Gurioli, G., Martignano, F., Salvi, S., Costantini, M., Gunelli, R., & Casadio, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0703 · Cited by 61

Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases

Menn, G. L., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 61

Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics

Foerster, S., Kacprowski, T., Dhople, V. M., Hammer, E., Herzog, S., Saafan, H., Bien-Möller, S., Albrecht, M., Völker, U., & Ritter, C. A. (2013) · PROTEOMICS · doi:10.1002/pmic.201300154 · Cited by 60

miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway

Shi, D.-M., Bian, X., Qin, C., & Wu, W. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s152611 · Cited by 60

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability

Zhao, W., Lü, D., Liu, L., Cai, J., Zhou, Y., Yang, Y., Zhang, Y., & Zhang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21280 · Cited by 59

PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma

Lei, B., Qi, W., Zhao, Y., Li, Y., Liu, S., Xu, X., Chen, Z., Wan, L., & Shen, H. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.07.026 · Cited by 57

Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells

Takei, N., Yoneda, A., Sakai, K., Kosaka, M., Minomi, K., & Tamura, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-09976-7 · Cited by 57

Gremlin is Overexpressed in Lung Adenocarcinoma and Increases Cell Growth and Proliferation in Normal Lung Cells

Mulvihill, M. S., Kwon, Y.-W., Lee, S. C. L., Fang, L. T., Choi, H., Ricchetti, R. R., Kang, H. C., Mao, J., Jablons, D. M., & Kim, I.-J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042264 · Cited by 56

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer

Dou, F., Li, H., Zhu, M., Liang, L., Zhang, Y., Yi, J., & Zhang, Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0791-2 · Cited by 56

Towards a general-purpose foundation model for computational pathology

Chen, R. J., Ding, T., Lu, M. Y., Williamson, D. F. K., Jaume, G., Song, A. H., Chen, B., Zhang, A., Shao, D., Shaban, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02857-3 · Cited by 1,560

Modulation of cellular processes by histone and non-histone protein acetylation

Shvedunova, M., & Akhtar, A. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00441-y · Cited by 1,007

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

Tan, A. C., & Tan, D. S. W. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01626 · Cited by 810

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578

Neutrophils in cancer carcinogenesis and metastasis

Xiong, S., Dong, L., & Cheng, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01187-y · Cited by 576

Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures

Satpathy, S., Clark, N. M., Chen, Y., Hosseini, N., Chang, Y.-H., Hsiao, Y., Lei, J. T., Petralia, F., Chen, J., Geffen, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.011 · Cited by 23

A02 Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B. A., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.12.031 · Cited by 3

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Soltis, A. R., Bateman, N. W., Liu, J., Nguyen, T. M., Franks, T. J., Zhang, X., Dalgard, C. L., Viollet, C., Somiari, S., Yan, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100819 · Cited by 83

Abstract 5893: Comprehensive proteogenomic analysis and classification of lung adenocarcinoma

Soltis, A. R., Bateman, N. W., Conrads, T. P., Dalgard, C. L., Hu, H., Franks, T. J., Liu, J., Meerzaman, D. M., Petricoin, E. F., Chen, Q., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-5893

Integrative Proteomic Characterization of Human Lung Adenocarcinoma

Xu, J., Zhang, C., Wang, X., Zhai, L., Ma, Y., Mao, Y., Qian, K., Sun, C., Liu, Z., Jiang, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.043 · Cited by 617